ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RGT Argent Biopharma Limited

21.00
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argent Biopharma Limited LSE:RGT London Ordinary Share AU0000326647 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 21.00 20.00 22.00 21.00 21.00 21.00 84 08:00:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Argent Biopharma Share Discussion Threads

Showing 57676 to 57696 of 58275 messages
Chat Pages: Latest  2319  2318  2317  2316  2315  2314  2313  2312  2311  2310  2309  2308  Older
DateSubjectAuthorDiscuss
17/2/2011
14:06
This is a long article; would suggest that you have a long careful read.

Now tell me that other distributors,will not be eager to sign up with RGTnewco, after reading Metagenics press release and the comments from Dr.Jeff Bland.



--------------------------------------------------------------------------------






Nutrition Business Journal Awards Key Leaders for Advancing Industry in 2010
Key leaders in the nutrition industry will be honored by Nutrition Business Journal (NBJ) at the 14th annual NBJ Summit, July 19-22, and were featured in the annual Business Achievement Awards issue.

NBJ is the premier publication for the nutrition, natural, organic, dietary supplement and integrative medicine industries. The NBJ Awards give recognition to the industry's brightest stars who have made a significant impact in the fields of health, wellness and nutrition.

"The industry had another big year in terms of growth, science and sustainability, but lacked in innovation," said Marc Brush, editor-in-chief of NBJ. "Hopefully 2011 will be a risk-taking year for companies to invest more in product development."

Three companies were recognized for growth including: Nutra Bridge, Aker BioMarine and the largest player in the U.S. dietary supplement industry, NBTY.

Honored for efforts on behalf of the nutrition industry was Roy Upton, who established the American Herbal Pharmacopoeia in 1994, which has since revolutionized the use of and attitudes toward botanicals in America.

Scientific achievement awards went to Danisco for moving the field of probiotics forward in a major way and Tishcon for enhancing the bioavailability and credibility of CoQ10.

Pierre Fitzgibbon, president and CEO of Atrium Innovations received a Management Achievement award for his leadership and successful track record with numerous acquisitions.

Investment in the Future Awards went to Standard Process, recently recognized by the U.S. Department of Health and Human Services for its impressive employee wellness program; and Stratum Nutrition for rapid expansion beyond its core animal nutrition business and strategic relationships across the globe to spark product innovation.

Receiving an award for Education was Ikhlas Khan for his prestigious role at the University of Mississippi's National Center for National Products Research and as director of the Food and Drug Administration's Center of Excellence for Botanical Dietary Supplement Research. In these roles, Khan distinguishes dozens of botanicals from frauds and develops teaching courses for FDA inspectors, manufacturing companies and trade groups on properly identifying botanical products.

Stonyfield Farm was honored for its environmental and sustainability decisions that have steered the company for the past 27 years. In 2010, Stonyfield completely eliminated petroleum-based plastics in its multipack yogurt cups, replacing them with polylactic acid plastic made from corn, reducing greenhouse gas emissions by 48 percent.

For her painstakingly researched indictment of chemical farming and its negative impact on human health, Maria Rodale, CEO of multimedia giant, Rodale Inc., was given an Organic Excellence award for her book, Organic Manifesto, that's designed to be a wake-up call to consumers about the urgency for organic farming expansion. And Alacer, maker of Emergen-C vitamin-drink mixes, received a Philanthropy award for aligning with charities such as Keep a Breast Foundation, Surfrider Foundation and Operation Gratitude and giving back a percentage of product sales with every purchase made by consumers.

Two awards were given for outstanding stock performance: Whole Foods Market, for the second straight year, and Medifast for its significant growth cycle.

Ten companies were recognized for being involved with the most impressive nutrition industry deals of 2010, including: Carlyle Group's purchase of NBTY for $4 billion; BASF's acquisition of Cognis for $3.8 billion; KeHE Food Distributer's purchase of natural and organic distributer Tree of Life; ConAgra's purchase of Elan Nutrition; Metagenics' acquisition of Bariatric Advantage; Trygg Pharma's purchase of EPAX; Martek Biosciences purchase of Amerifit Brands; Diversified Natural Products merger with Thorne Research; Diamond Foods acquisition of natural potato chip company, Kettle Foods; and TPG Growth's 25 percent stake in supplement marketer Schiff Nutrition for $48.8 million.

The Business Achievement Awards issue published in January also includes a question and answer with one of advertising's most influential creative directors, Alex Bogusky formally of Crispin Porter + Bogusky, and recent founder of consumer advocacy group, FearLess Cottage; in addition to interviews with Council for Responsible Nutrition's Steve Mister and Inventages' Wolfgang Reichenberger.

NBJ publisher Patrick Rea, along with Brush will publicly honor all award recipients at the NBJ Summit in Dana Point, Calif. During the prestigious awards dinner, the recipient of the 2010 Lifetime Achievement award will be announced. Last year, there were two recipients: Robert Orr, president and chief executive officer of Ocean Nutrition Canada, and Steve Allen, former vice president of new ventures for Nestlé. For more information about the NBJ Summit visit www.nbjsummit.com. To subscribe to NBJ visit: www.nutritionbusinessjournal.com.

Through a portfolio of media products, including a monthly executive journal and in-depth research reports, NBJ supplies authoritative data and analysis to leaders and decision makers in the nutrition business. NBJ also provides strategic consulting services to many of the top companies in the industry. To request a free issue of NBJ visit: www.nutritionbusinessjournal.com.

share_shark
17/2/2011
13:35
Gant,

Hope they have mobile phones on all time.....................LOL!!!

maysun
17/2/2011
13:34
Sorry forgot about PL but I gather he is staying as a consultant so I don't see that as front line.
gantenbrink
17/2/2011
13:33
I am waiting to buy some more at 0.75p,any chance?
maysun
17/2/2011
13:33
Have we had any indication as to how much time the two Directors will apportion to Regen as against there other interests? Just thinking practically is there going to be a manned phone line at all times with just 2 of them working part time.
gantenbrink
17/2/2011
13:32
mchugh01, I thought that PL was being kept on as advisor to Newco on a £10k p.a retainer?
mike111d
17/2/2011
13:29
Mike

The main protagonist(liar/crook/fraudster...please fill in as appropriate) has gone.
The two guys left in charge will be ably supported by others outside of the BoD.
If PL had been in charge I would have been gone for good.

The product is good and has been tried and tested.
The problem is that we had a Chairman who was only in it for himself until he saw another gravy train he could ride out into the sunset. All in my opinion, of course.
I said a long time ago that the product will succeed in spite of Lomax and I still believe this to be true.
--------------------------------------

Alby - why are you still holding if you think it won't succeed? I can't get my head round that one?

mchugh01
17/2/2011
13:22
mchugh01, I was quite open at the time about buying off the lows and was lucky to sell above 3p on the rise, clearly it does not always work out that way.

As for Eirx it is a different scenario but yes I am very positive about the outcome, albeit that it will be over two years from when they delisted when they finally make their return. A big difference for me in respect of Eirx v Regen is that I have faith in the BOD there to deliver, whereas I have never had much confidence in the BOD here. With Regen I was buying into the product rather than the boards capability to deliver.

mike111d
17/2/2011
13:18
I agree mike, i also have doubts about this last "armageddon Rns" it just perpetrates a company that really a one trick pony that up to now after all these years and money gone has achieved very little imo. And as for the oiler with P.L on board and little money imo i doubt it will show a credable future
alby220
17/2/2011
13:14
Mike

by his own admission R&K did not make a profit.
And of course, you love to tell everyone you allegedly made a profit out of Regen.
ps are the streets always paved with gold where you live?...lol

----------------------------------------------------------

...the demerger, which I still find a little suspicious....

quite obvious in my opinion.
Lomax saw he was not going to last and decided to cut his jib to suit. Shafted the shareholders long enough until he as his new accomplices decided to use RGT as a shell company for their proposed gravy train. The man ought to be locked up in my opinion.

As far as the demerger is concerned you don't seem to be bothered too much when it happens to your beloved eirx.

mchugh01
17/2/2011
13:00
R&K, just providing an honest opinion. Yes I was positive back in December as the news flow stepped up and the price was rising but then came the body blow Re the demerger, which I still find a little suspicious. Thankfully and as you I had already booked a good profit here but I still feel for the long term holders of RGT, as they deserved better IMO.
mike111d
17/2/2011
12:57
'logic would say otherwise'

logic would say that the company has the best prospects of hitting profitability than it ever has

Many here dont see it as problematic holding a BETTER private company that looking at past revenues and recent distribution factors, actually stands a healthy chance of being a success

the_doctor
17/2/2011
12:52
Mike111D,

Yes, as you said, holding this share is optional.

That's why after the de-merger announcement, some sold and some bought.

I personally finds the Mateganics re-launch a very encouraging and now feel happy to invest in the private company...............

maysun
17/2/2011
12:50
Don't we all rob? :)
greedfear
17/2/2011
12:46
Of course not.

The Mateganics re-launch actually gives new RGt a good base to move forward...................LOL!!!

maysun
17/2/2011
12:44
No but the company in which people invested in is about to go off market for an indeterminate period of time. Leaving a holding in an E&P play which I suspect in the main most may not invest in if it were optional.
mike111d
17/2/2011
12:43
Hmmm...I think there's something else going on.
greedfear
17/2/2011
12:42
although mike we arnt going into administration are we....
doorway
17/2/2011
12:40
With any stock there will always be those who are emotionally attached and will continue to buy when logic would say otherwise, I witnessed the same with folk throwing good money after bad at HML in its run up to administration.
mike111d
17/2/2011
12:39
Alby220,

What is the latest quote, alby Jenkins?

Pls keep it sensible, otherwise there won't be buyers.



LOL!!!

maysun
17/2/2011
12:37
Yes, what do you make of that? :)
greedfear
Chat Pages: Latest  2319  2318  2317  2316  2315  2314  2313  2312  2311  2310  2309  2308  Older